• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发和验证一种新的列线图,用于预测肝癌根治性肝切除术后 10 年实际生存率。

Development and validation of a novel nomogram predicting 10-year actual survival after curative hepatectomy for hepatocellular carcinoma.

机构信息

Department of Surgery, The Chinese University of Hong Kong, Hong Kong; Department of Surgery, Prince of Wales Hospital, New Territories, Hong Kong.

Department of Surgery, Prince of Wales Hospital, New Territories, Hong Kong.

出版信息

Surgeon. 2021 Dec;19(6):329-337. doi: 10.1016/j.surge.2020.11.013. Epub 2021 Jan 8.

DOI:10.1016/j.surge.2020.11.013
PMID:33423927
Abstract

INTRODUCTION

Although hepatectomy is a curative treatment modality for hepatocellular carcinoma (HCC), the associated 10-year long-term actual survival are rarely reported. This study aims to develop and validate a predictive nomogram for 10-year actual survivors with HCC.

MATERIALS AND METHODS

From 2004 to 2009, 753 patients with curative hepatectomy for HCC (development set, n = 325; validation set, n = 428) were included. In development set, comparison of clinic-pathological data was made between patients surviving ≥10 years and those surviving <10 years. Good independent prognostic factors identified by multivariate analysis were involved in a nomogram development, which was validated internally and externally using validation set.

RESULTS

On multivariate analysis, five independent good prognostic factors for 10-year survival were identified, including young age (OR = 0.943), good ASA status (≤2) (OR = 2.794), higher albumin level (OR = 1.116), solitary tumor (OR = 2.531) and absence of microvascular invasion (OR = 3.367). A novel nomogram was constructed with C-index of 0.801 (95% CI 0.762-0.864). A cut-off point of 167.5 had a sensitivity of 0.794 and specificity of 0.730. Internal validation using bootstrap sampling and external validation using validation set revealed C-index of 0.792 (95% CI, 0.741-0.853) and 0.761 (95% CI, 0.718-0.817).

CONCLUSION

A novel nomogram for 10-year HCC survivor using age, ASA status, preoperative albumin, tumor number and presence of microvascular tumor invasion was developed and validated with high accuracy.

摘要

简介

虽然肝切除术是治疗肝细胞癌(HCC)的一种根治性治疗方法,但很少有报道其 10 年的实际长期生存率。本研究旨在建立和验证一种预测 HCC 患者 10 年实际生存者的预测列线图。

材料和方法

从 2004 年到 2009 年,共纳入 753 例接受根治性肝切除术治疗 HCC 的患者(发展集,n=325;验证集,n=428)。在发展集中,比较了生存时间≥10 年和<10 年的患者的临床病理数据。通过多因素分析确定了良好的独立预后因素,并将其纳入列线图的建立,然后使用验证集进行内部和外部验证。

结果

多因素分析确定了 5 个与 10 年生存相关的独立良好预后因素,包括年龄较小(OR=0.943)、良好的美国麻醉医师协会(ASA)状态(≤2)(OR=2.794)、较高的白蛋白水平(OR=1.116)、单发肿瘤(OR=2.531)和无微血管侵犯(OR=3.367)。建立了一个新的列线图,C 指数为 0.801(95%CI,0.762-0.864)。截断值为 167.5 时,灵敏度为 0.794,特异性为 0.730。使用 bootstrap 抽样进行内部验证和使用验证集进行外部验证,C 指数分别为 0.792(95%CI,0.741-0.853)和 0.761(95%CI,0.718-0.817)。

结论

使用年龄、ASA 状态、术前白蛋白、肿瘤数量和微血管肿瘤侵犯的存在,建立并验证了一种预测 HCC 患者 10 年生存者的新型列线图,具有较高的准确性。

相似文献

1
Development and validation of a novel nomogram predicting 10-year actual survival after curative hepatectomy for hepatocellular carcinoma.开发和验证一种新的列线图,用于预测肝癌根治性肝切除术后 10 年实际生存率。
Surgeon. 2021 Dec;19(6):329-337. doi: 10.1016/j.surge.2020.11.013. Epub 2021 Jan 8.
2
Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy.开发并验证了一个列线图模型,用于评估肝癌患者肝切除术后的生存情况。
Biosci Rep. 2020 Jun 26;40(6). doi: 10.1042/BSR20192690.
3
A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.基于影像组学的Nomogram 模型预测肝癌患者肝切除术后的总生存情况
Cancer Imaging. 2020 Nov 16;20(1):82. doi: 10.1186/s40644-020-00360-9.
4
Nomograms to Predict the Individual Survival of Patients with Solitary Hepatocellular Carcinoma after Hepatectomy.列线图预测肝癌术后单发肿瘤患者的个体生存情况。
Gut Liver. 2017 Sep 15;11(5):684-692. doi: 10.5009/gnl16465.
5
Development and validation of a nomogram for survival prediction in hepatocellular carcinoma after partial hepatectomy.开发并验证肝癌部分肝切除术后生存预测的列线图。
BMC Surg. 2023 Jan 30;23(1):27. doi: 10.1186/s12893-023-01922-x.
6
Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy: A bimodal distribution.肝细胞癌患者根治性肝切除术后实际中期(≥5年)和长期(≥10年)生存结果的单中心经验:双峰分布。
Medicine (Baltimore). 2020 Nov 25;99(48):e23358. doi: 10.1097/MD.0000000000023358.
7
Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection.预后列线图对根治性切除术后无门静脉肿瘤血栓形成的肝细胞癌患者的生存情况进行分层。
Oncologist. 2017 May;22(5):561-569. doi: 10.1634/theoncologist.2016-0231. Epub 2017 Apr 24.
8
Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.基于炎症相关标志物的新型预后列线图模型用于评估接受肝切除术的肝细胞癌患者。
Cancer Res Treat. 2019 Oct;51(4):1464-1478. doi: 10.4143/crt.2018.657. Epub 2019 Mar 11.
9
Nomogram predicting long-term survival after the diagnosis of intrahepatic recurrence of hepatocellular carcinoma following an initial liver resection.预测初次肝切除术后肝细胞癌肝内复发诊断后长期生存的列线图。
Int J Clin Oncol. 2017 Aug;22(4):715-725. doi: 10.1007/s10147-017-1114-1. Epub 2017 Mar 16.
10
A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.腹腔镜肝切除术后预测肝细胞癌复发的列线图。
Cancer Commun (Lond). 2019 Oct 11;39(1):55. doi: 10.1186/s40880-019-0404-6.

引用本文的文献

1
Development of an individualized model for predicting postoperative delirium in elderly patients with hepatocellular carcinoma.开发一种个体化模型预测老年肝细胞癌患者术后谵妄。
Sci Rep. 2024 May 22;14(1):11716. doi: 10.1038/s41598-024-62593-z.
2
Comparison of clinical outcome between laparoscopic and open hepatectomy of high difficulty score for hepatocellular carcinoma: a propensity score analysis.腹腔镜与开腹肝切除术治疗高难度评分肝细胞癌的临床疗效比较:倾向评分分析。
Surg Endosc. 2024 Feb;38(2):857-871. doi: 10.1007/s00464-023-10634-5. Epub 2023 Dec 11.
3
Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma.
青少年及青年期乙型肝炎相关肝细胞癌的临床预后及相关分子特征。
Hum Genomics. 2023 Jun 13;17(1):52. doi: 10.1186/s40246-023-00500-9.
4
Asia-Pacific multicentre randomized trial of laparoscopic versus open major hepatectomy for hepatocellular carcinoma (AP-LAPO trial).亚太地区腹腔镜与开腹肝癌根治术治疗肝细胞癌的多中心随机对照临床试验(AP-LAPO 试验)。
BJS Open. 2023 Jan 6;7(1). doi: 10.1093/bjsopen/zrac166.
5
A Predictive Nomogram of Early Recurrence for Patients with AFP-Negative Hepatocellular Carcinoma Underwent Curative Resection.接受根治性切除的甲胎蛋白阴性肝细胞癌患者早期复发的预测列线图。
Diagnostics (Basel). 2022 Apr 25;12(5):1073. doi: 10.3390/diagnostics12051073.
6
Nomograms for Predicting Hepatocellular Carcinoma Recurrence and Overall Postoperative Patient Survival.预测肝细胞癌复发及患者术后总体生存的列线图
Front Oncol. 2022 Feb 28;12:843589. doi: 10.3389/fonc.2022.843589. eCollection 2022.